Author - Barbara Handelin

Barbara Handelin, PhD is cofounder and CEO of Audacity Therapeutics, a public benefit (B Corp) pharmaceutical company which is seeding a new public benefit industry, operating in green practices and delivering drugs at a cost for a sustainable healthcare economy. She is a veteran entrepreneur and molecular medical geneticist who has pioneered the responsible application of genetics and molecular innovation to clinical medicine over a 35 year career. In 1987 Dr. Handelin established the first commercial DNA testing laboratories at Integrated Genetics (later Genzyme Genetics). She also co-founded Genovo), a biosimulation company, (Kenna Technologies). and BioPontis Alliance, a novel investment fund. Dr. Handelin has served on the board of several genomics companies (EXACT, RedPath IP, Stemina BioSciences) as well as on a variety of federal committees and advisory panels on ethics in genetic testing, including the Secretary’s Advisory Panel on Genetics, Health and Society.